Cell Biology

P. Nurse, "Universal control mechanism regulating onset of M-phase," Nature, 344, 503-8, 5 April 1990. Paul Nurse (University of Oxford, England): "This paper reviews the area of cell cycle control, which is going through an exciting period at present (The Scientist, Dec. 10, 1990, page 15). Two approaches, a genetics one using yeast and a biochemical one using egg extracts, have converged on the same gene products as being important for regulating the onset of M-phase and cell division. In pa

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

P. Nurse, "Universal control mechanism regulating onset of M-phase," Nature, 344, 503-8, 5 April 1990.

Paul Nurse (University of Oxford, England): "This paper reviews the area of cell cycle control, which is going through an exciting period at present (The Scientist, Dec. 10, 1990, page 15). Two approaches, a genetics one using yeast and a biochemical one using egg extracts, have converged on the same gene products as being important for regulating the onset of M-phase and cell division. In particular, a protein kinase complex composed of p34cdc2and cyclin has been shown to be responsible for initiation of M-phase, with activation of kinase activity being brought about by p34cdc2 dephosphorylation. "This paper reviews the features of this control system likely to be common to all eukaryotic cells. This analysis has led to the idea that a universal mechanism, broadly similar in all eukaryotic cells ranging from yeast to humans, regulates ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies